ArticleSN comprehensive clinical medicine2020
Epidemiological and Clinical Characteristics of 6635 COVID-19 Patients: a Pooled Analysis.
Article in SN comprehensive clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 6 syntheses or guidelines pooled it, 56 citations in OpenAlex.
- Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.The journal of headache and pain · 2022Pooled it
- Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis.Journal of medical virology · 2022Pooled it
- Outcomes of COVID-19 Complications and their Possibilities as Potential Triggers of Stroke.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2021Pooled it
- Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis.BMJ evidence-based medicine · 2021Pooled it
- A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations.Infectious diseases (London, England) · 2021Pooled it
- Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis.Journal of medical virology · 2021Pooled it
- Acute and chronic kidney injury following COVID-19 infection and vaccination: a narrative review.European journal of translational myology · 2026Article
- Gastrointestinal Manifestations and Outcomes of COVID-19: A Comprehensive Systematic Review and Meta-analysis.Cureus · 2023Review
- Quality of Life 6 Months after COVID-19 Hospitalisation: A Single-Centre Polish Registry.Journal of clinical medicine · 2023Article
- The usability of neopterin in determining disease course in COVID-19.Saudi medical journal · 2023Article
- Emergency laparoscopic trans-abdominal pre-peritoneal repair (TAPP) for irreducible inguinal hernia in Covid-19 patient: A case report and literature review.International journal of surgery case reports · 2023Article
- The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity.Clinical biochemistry · 2022Review
- COVID-19 and chronic kidney disease: an updated overview of reviews.Journal of nephrology · 2022Review
- Association of systemic complications with mortality in coronavirus disease of 2019: A cohort study on intensive care unit patients.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2022Article
- Correlation Between Coronavirus Disease 2019 and Olfactory Dysfunction.Frontiers in public health · 2022Review
- Headache Attributed to SARS-CoV-2 Infection or COVID-19 Related Headache-Not Migraine-like Problem-Original Research.Brain sciences · 2021Article
- Comparative transcriptomic analysis of SARS-CoV-2 infected cell model systems reveals differential innate immune responses.Scientific reports · 2021Article
- Prognostic performance of CHA₂DS₂-VASc scores for predicting mortality among COVID-19 patients: A single pandemic center experience.The American journal of emergency medicine · 2021Article
- A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic.Journal of medical virology · 2021Review
- Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort.Brain sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An unidentified pneumonia outbreak was first observed in Wuhan, the capital of Hubei Province, China, in December 2019. WHO officially named the disease, Coronavirus Disease 2019 (COVID-19), and declared it as pandemic on Mar 11, 2020. Globally, there are more than 3 million confirmed cases with nearly 200,000 deaths. Hence, we aimed to perform a systematic review and pooled analysis of the current published literature on COVID-19 to provide an insight on the epidemiological and clinical characteristics of COVID-19 patients. A systematic search of published peer-reviewed articles that reported cases with demographical and clinical features of real-time reverse transcriptase polymerase chain reaction (rRT-PCR)-confirmed SARS-CoV-2 infection using MOOSE guidelines was conducted from December 1, 2019, to April 27, 2020, and 50 eligible articles were included for the final analysis. Review articles, opinion articles, and letters not presenting original data as well as studies with incomplete information were excluded. We included a total of 6635 patients from 50 articles, with 54.5 % being male. The predominant symptoms were fever (80.3%), cough (64.2%), and fatigue/myalgia (36.5%) and other symptoms including dyspnea, chest pain, and sore throat. We also found patients with GI symptoms like diarrhea (9.2%) and nausea/vomiting (5.2%). Comorbidities were found in 3,435 (51.7%) patients with the most common being hypertension (22.67%) followed by diabetes mellitus (12.78%). COVID-19 pandemic is not only leading a huge burden on health care facilities but significant disruption in the world society. Patients with coexisting comorbidities are at higher risk and need more utilization of health care resources. As this virus is spreading globally, all countries have to join hands and prepare at all levels of human resources, infrastructure, and facilities to combat the COVID-19 disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.